ReviewCurrent psychiatry reports2010
Comparison of available treatments for tobacco addiction.
Review in Current psychiatry reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 53 citations in OpenAlex.
- The effect of nicotine patches on craving in the brain: A functional MRI study on heavy smokers.Medicine · 2018Trial
- Smoking and opioid detoxification: behavioral changes and response to treatment.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013Trial
- Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.Psychopharmacology · 2012Trial
- Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.Psychopharmacology · 2012Trial
- Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study.The American journal on addictionsTrial
- Truck Drivers' Cigarette Smoking and Preferred Smoking Cessation Methods.Substance abuse : research and treatment · 2020Article
- Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.Drug and alcohol dependence · 2017Observational
- The Epidemiology of Antisocial Behavioral Syndromes in Adulthood: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.The Journal of clinical psychiatry · 2017Article
- The Epidemiology of DSM-5 Nicotine Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.The Journal of clinical psychiatry · 2016Article
- In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone.Psychopharmacology · 2016Article
- Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use.Drug and alcohol dependence · 2015Article
- Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models.Neurochemical research · 2015Article
- Treatment models for targeting tobacco use during treatment for cannabis use disorder: case series.Addictive behaviors · 2014Article
- Efficacy of Resistance Training as an Aid to Smoking Cessation: Rationale and Design of the Strength To Quit Study.Mental health and physical activity · 2014Article
- Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic.Multidisciplinary respiratory medicine · 2014Article
- Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.British journal of clinical pharmacology · 2014Review
- The DNA methylation signature of smoking: an archetype for the identification of biomarkers for behavioral illness.Nebraska Symposium on Motivation. Nebraska Symposium on Motivation · 2014Review
- Current and emerging pharmacotherapeutic options for smoking cessation.Substance abuse : research and treatment · 2013Article
- Long-acting Preparations in Substance Abuse Management: A Review and Update.Indian journal of psychological medicine · 2013Article
- Mice lacking the β4 subunit of the nicotinic acetylcholine receptor show memory deficits, altered anxiety- and depression-like behavior, and diminished nicotine-induced analgesia.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Cigarette smoking is a major public health problem that causes more than 5 million deaths annually worldwide. Cigarette smoking is especially common among individuals with psychiatric comorbidity, including individuals with primary psychiatric disorders and other addictions. Effective behavioral and pharmacologic treatments for smoking cessation are available. Behavioral treatments including brief (< 3 min) counseling by physicians are effective. Seven first-line pharmacologic treatments are currently available: five nicotine replacement therapies, bupropion, and varenicline. In addition, clonidine and nortriptyline are second-line treatments for smoking cessation. These treatments increase the chances of quitting smoking by two- to threefold, supporting their use in smokers who are motivated to quit. However, effective treatments for many subpopulations, including smokers with psychiatric comorbidities as well as adolescent, pregnant, or postpartum smokers, remain to be developed and represent an important challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.